The GalNAc-T Activation (GALA) Pathway: Drivers and markers

Area of Science:

• Biochemistry
• Cell Biology
• Cancer Research

Background:

• O-glycosylation, initiated by GALNTs enzymes adding GalNAc sugars, is critical for cellular functions.
• The GALNTs activation (GALA) pathway, involving Golgi-to-ER trafficking, drives liver tumor progression.
• Previous studies contested the role of EGF in inducing GALNTs relocation, a key aspect of GALA.

Purpose of the Study:

• To re-evaluate the effect of EGF stimulation on GALNTs relocation.
• To investigate the role of EGFR in the GALA pathway.
• To identify novel methods for quantifying GALA.

Main Methods:

• Re-analysis of previously published imaging data.
• Over-expression of EGFR and assessment of EGF-induced GALNTs relocation.
• Co-localization studies using ER markers (Calnexin).
• Quantification of PDIA4 O-glycosylation as a GALA marker.

Main Results:

• EGF-induced GALNTs relocation is detectable, even in previously contested data.
• EGFR overexpression enhances EGF-induced relocation.
• EGFR is required for relocation induced by ERK8 depletion.
• Direct co-localization of GALNTs with Calnexin confirms ER trafficking.
• PDIA4 O-glycosylation serves as a reliable GALA quantification method.

Conclusions:

• The non-reproducibility claims were attributed to experimental imaging conditions.
• EGFR is confirmed as a driver of the GALA pathway.
• New markers are proposed to aid future GALA pathway research.